Sirolimus
Jump to navigation
Jump to search
| Sirolimus | |
|---|---|
| Term | Sirolimus |
| Short definition | Sirolimus - (pronounced) (sih-ROH-lih-mus) drug used to stop the body from rejecting organ and bone marrow transplants. Sirolimus blocks certain white blood cells that can shed foreign tissues and organs. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Sirolimus - (pronounced) (sih-ROH-lih-mus) drug used to stop the body from rejecting organ and bone marrow transplants. Sirolimus blocks certain white blood cells that can shed foreign tissues and organs. It also blocks a protein involved in cell division. It's a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Sirolimus was formerly called rapamycin. Also called Rapamune
External links
- Medical encyclopedia article on Sirolimus
- Wikipedia's article - Sirolimus
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski